Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2005
04/21/2005WO2005035572A2 Antibody compositions and methods
04/21/2005WO2005035567A1 Chimeric mhc protein and oligomer thereof for specific targeting
04/21/2005WO2005035563A1 Process for producing antithrombin iii composition
04/21/2005WO2005035562A1 Novel cell growth promoter
04/21/2005WO2005035559A1 Isolated photoprotein mtclytin, and use thereof
04/21/2005WO2005035558A2 Piscirickettsia salmonis antigens and use thereof
04/21/2005WO2005035550A2 Dual phase-pna conjugates for the delivery of pna through the blood brain barrier
04/21/2005WO2005035547A2 E2f oligonucleotide decoy molecules
04/21/2005WO2005035546A1 Peptide nucleic acid conjugates and uses thereof
04/21/2005WO2005035004A1 COMPOSITION FOR INHIBITING FUNCTION OF HUMAN Flt3
04/21/2005WO2005034993A1 Vp1 fusion protein vaccin of recombinant foot-and-mouth disease virus
04/21/2005WO2005034984A1 Cd44 splice variant in diagnosis and therapy of intestinal cancer
04/21/2005WO2005034876A2 Use of cell lines to produce active therapeutic proteins
04/21/2005WO2005034853A2 Uses of interferons with altered spatial structure
04/21/2005WO2005034841A2 Anthrax vaccine
04/21/2005WO2005034733A2 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
04/21/2005WO2005021705A3 Citrus sesquiterpene synthase, methods of production and uses thereof
04/21/2005WO2005017129B1 Phosphoramide and uses thereof
04/21/2005WO2005017108A3 Soybean selection system based on aec-resistance
04/21/2005WO2005016970A3 Fully human antibodies directed against the human insulin-like growth factor-1 receptor
04/21/2005WO2005016969A3 Cd20-binding polypeptide compositions
04/21/2005WO2005014817A3 Chordin-like homologs
04/21/2005WO2005014631A9 Fungus resistant plants and their uses
04/21/2005WO2005012517A3 Use of the fret phenomenon for in vivo follow-up of biological events
04/21/2005WO2005012341A3 Pichia methanolica secretory signal
04/21/2005WO2005010047A3 Antiangiogenic compounds, pharmaceutical composition containing said compounds and the use thereof
04/21/2005WO2005003362A3 Methods to confer herbicide resistance
04/21/2005WO2004113541A3 Plant transcriptional activator and uses thereof
04/21/2005WO2004113501A3 Methods and compositions relating to lipid accumulation
04/21/2005WO2004108940A3 Viral genome vectors
04/21/2005WO2004104199A3 Modulation of gene expression using dna-dna hybrids
04/21/2005WO2004103268A3 Intracellular production of specific rna molecules by splicing
04/21/2005WO2004099447A3 Corn event tc1507 and methods for detection thereof
04/21/2005WO2004098490A3 Mesoderm and definitive endoderm cell populations
04/21/2005WO2004096987A3 A forward mutation assay based on 5-fluorouracil resistance
04/21/2005WO2004090110A3 Compositions and methods for the control, differentiation and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway
04/21/2005WO2004089423A3 Pharmico-gene theraphy of epithelial sodium channel associated disoders
04/21/2005WO2004087746A3 Staphylococcus epidermidis antigens
04/21/2005WO2004083388A3 Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
04/21/2005WO2004080378A3 Methods and tools for screening active rna in cellulo
04/21/2005WO2004078918A3 Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides
04/21/2005WO2004074507A3 Method to confer cell culture replication activity to different hepatitis c virus isolates
04/21/2005WO2004073657A3 Methods of diagnosis of cancer and other diseases, composition and methods of screening for modulators of cancer and other diseases
04/21/2005WO2004071462A3 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction
04/21/2005WO2004069992A3 Oligomeric compounds for the modulation of ras expression
04/21/2005WO2004053103A3 METHOD OF INTRODUCING siRNA INTO ADIPOCYTES
04/21/2005WO2004048545A3 DELIVERY OF siRNAs______________________________________________
04/21/2005WO2004048514A3 Methods for analyzing a nucleic acid
04/21/2005WO2004045543A3 Functional and hyperfunctional sirna
04/21/2005WO2004031142A3 Inhibition of metallo-beta-lactamase
04/21/2005WO2004021978A3 Antisense modulation of endothelial specific molecule 1 expression
04/21/2005WO2004020588A3 Transferrin fusion protein libraries
04/21/2005WO2004018066A3 Aqueous two-phase systems for particle manipulation and encapsulation within microscopic volumes
04/21/2005WO2004011623A3 Antisense modulation of ptpra expression
04/21/2005WO2004009802A3 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS
04/21/2005WO2004009768A3 Viral vectors containing recombination sites
04/21/2005WO2004000010A3 Animal models of prostate cancer and methods for their use
04/21/2005WO2003106639A3 Recombination of nucleic acid library members
04/21/2005WO2003105753A3 Targeted enzymes and methods of making and using targeted enzymes.
04/21/2005WO2003104394A3 Nucleic acid molecules encoding a transmembrane serine protease 12, the encoded polypeptides and methods based thereon
04/21/2005WO2003070189A3 Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
04/21/2005WO2003069311A3 Methods and compositions for use in spliceosome mediated rna trans-splicing
04/21/2005WO2003048349A8 Acetoacetyl-coa thiolase and use of for the identification of novel fungicidal substances
04/21/2005WO2003048339A3 Nucleic acid molecules from rice encoding rar1 disease resistance proteins and uses thereof
04/21/2005WO2003016478A3 G-protein coupled receptor polynucleotides and methods of use thereof
04/21/2005WO2003014696A3 Methods of identifying functional analogs of peptide regulators of biological pathways
04/21/2005WO2002099053A3 Slc22as as modifiers of the p53 pathway and methods of use
04/21/2005WO2002092842A3 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
04/21/2005WO2002092841A3 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
04/21/2005US20050086719 Glyphosate resistant maize lines
04/21/2005US20050086718 Plant transcriptional regulators of abiotic stress
04/21/2005US20050086716 Expression vector comprising nucleotide sequences coding sugary maize -2 gene (ISUM2A) for use as tool in generating transgenic crop plants with enhanced starch, plant oil or semolina production
04/21/2005US20050086714 Transforming internode stem segments of plant with non-hypervirulent agrobacterium strain and generating disease, heat, insect and/or herbicide resistant trees; tissue engineering; forestry and tree regrowth
04/21/2005US20050086713 Expression vector comprising nucleotide sequences coding 3-hydroxy-3-methylglutaryl-coenzyme a reductase for use in generation of transgenic plants with enhanced sterol production
04/21/2005US20050086712 Method to produce para-hydroxybenzoic acid in the stem tissue of green plants by using a tissue-specific promoter
04/21/2005US20050086711 Transgenic animals and methods for screening for anti-amyloidogenic agents and agents for treating neurodegenerative disease
04/21/2005US20050086709 7B2 knockout transgenic animals as models of endocrine disease
04/21/2005US20050086011 Information processing system using nucleotide sequence-related information
04/21/2005US20050085633 Generation of diversity in combinatorial libraries
04/21/2005US20050085627 Nucleotide sequences coding histone methyltransferase for use in identifying modulators for treatment and prevention of asthma disorders
04/21/2005US20050085519 Controlling cell differentiation, cell proliferation; anticancer agents
04/21/2005US20050085486 Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases
04/21/2005US20050085435 Novel inhibitors of poxvirus replication
04/21/2005US20050085427 Transfection agents
04/21/2005US20050085426 Acid-sensitive compounds, preparation and use thereof
04/21/2005US20050085419 Anti-growth factor receptor avidin fusion proteins as universal vectors for drug delivery
04/21/2005US20050085417 Compounds and methods for diagnostic imaging and therapy
04/21/2005US20050084972 Plasmid for transfer and expression of antitrypsin gene sequences in sacchromyces; bioreactors
04/21/2005US20050084971 Using trehalose metabolism as reporter function to identify transgenic plants
04/21/2005US20050084970 Using homolgous recombination of overlapping DNA sequences and vector cloning to generate artificial chromosome construct for transfer and manipulation of large DNA fragments to preferential host cells
04/21/2005US20050084969 Method for producing a recombinant polypeptide
04/21/2005US20050084968 Pluripotent stem cell for use as tool in propagation of cells, tissue and organs to treat disease
04/21/2005US20050084960 Propgating human embryonic stem cells in birds and generating specific tissues for use in treatment preferential organ deficiencies; tissue engineering and regenerative medicine
04/21/2005US20050084947 Recombinant RSV virus expression systems and vaccines
04/21/2005US20050084946 E.g., 5-indolyl methyl hydantoin, 5-(p-hydroxybenzyl) hydantoin, 5-isobutyl hydantoin, and 5-(3'-pyridyl)-methyl hydantoin; efficiently catalyzes racemization reactions at a high optimum temperature
04/21/2005US20050084945 Genes encoding denitrification enzymes
04/21/2005US20050084938 Method for plasmid preparation by conversion of open circular plasmid to supercoiled plasmid
04/21/2005US20050084936 Human regulatory proteins
04/21/2005US20050084934 System for expressing hyperthermostable protein
04/21/2005US20050084928 Transgenic cells comprising transfected glutamine synthetase gene for use as bioreactor in propagation of heterologous proteins
1 ... 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 ... 4023